Profile data is unavailable for this security.
About the company
PharmaSGP Holding SE is a Germany based company, which operates as a pharmaceutical company. The Company produces and develops non-chemical and over-the-counter drugs and other healthcare products.
- Revenue in EUR (TTM)109.76m
- Net income in EUR18.21m
- Incorporated2020
- Employees93.00
- LocationPharmaSGP Holding SELochhamer Schlag 21GRAEFELFING 82166GermanyDEU
- Phone+49 898 589639150
- Fax+49 898 589639201
- Websitehttps://pharmasgp.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PharmaSGP Holding SE | 109.76m | 18.21m | 297.60m | 93.00 | 16.33 | 9.12 | 10.78 | 2.71 | 1.52 | 1.52 | 9.15 | 2.72 | 0.8223 | 1.04 | 8.57 | 1,233,225.00 | 13.64 | 13.70 | 18.34 | 19.98 | 90.91 | 90.20 | 16.59 | 17.56 | 1.54 | 14.98 | 0.6823 | -- | 17.80 | 10.78 | 37.17 | 2.16 | 25.88 | -- |
| Shanghai Shen Lian Biomedical Corp | 40.66m | -2.58m | 298.58m | 380.00 | -- | 1.56 | -- | 7.34 | -0.048 | -0.048 | 0.7558 | 3.56 | 0.1944 | 1.16 | 0.9692 | 816,747.00 | -1.48 | 5.39 | -1.58 | 5.84 | 60.66 | 77.45 | -7.62 | 25.48 | 5.14 | -- | 0.0012 | 38.49 | -8.25 | 1.85 | -48.41 | -18.49 | 10.47 | -- |
| Alliance Pharma plc | 220.30m | -40.39m | 299.43m | 290.00 | -- | 1.12 | -- | 1.36 | -0.0622 | -0.0622 | 0.3378 | 0.4124 | 0.4016 | 2.72 | 4.67 | 627,215.80 | -7.36 | -0.5982 | -8.08 | -0.6566 | 59.42 | 62.45 | -18.34 | -1.80 | 2.06 | 4.45 | 0.3218 | -- | 7.92 | 8.86 | -56.24 | -- | -25.01 | -- |
| Cuorips Inc | 118.06k | -4.01m | 300.64m | 59.00 | -- | 8.43 | -- | 2,546.57 | -88.11 | -88.11 | 2.60 | 729.16 | 0.0032 | 1.15 | 10.60 | 328,610.20 | -10.89 | -- | -11.14 | -- | 44.66 | -- | -3,394.40 | -- | 35.37 | -- | 0.00 | -- | -39.65 | -- | -39.84 | -- | -- | -- |
| Shanghai Serum Bio-Technology Co Ltd | 25.85m | 6.67m | 301.14m | 321.00 | 45.14 | 2.06 | -- | 11.65 | 0.4706 | 0.4706 | 1.82 | 10.30 | 0.1735 | 1.14 | 3.91 | 614,647.90 | 4.48 | 10.43 | 4.56 | 10.84 | 76.60 | 80.54 | 25.81 | 32.57 | 42.72 | -- | 0.004 | 64.93 | 9.14 | 5.67 | -39.54 | -1.62 | 13.07 | -- |
| Flerie AB | 8.62k | -23.22m | 301.74m | 2.00 | -- | 0.8217 | -- | 35,020.59 | -22.07 | -22.07 | 0.0019 | 54.59 | 0.00004 | -- | -- | 14,285.71 | -11.53 | -37.64 | -11.69 | -41.14 | -92,017.00 | -450.51 | -269,618.00 | -454.62 | -- | -2.58 | 0.0002 | -- | -- | 277.02 | 5.05 | -- | -- | -- |
Data as of Nov 14 2024. Currency figures normalised to PharmaSGP Holding SE's reporting currency: Euro EUR
10.28%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Union Investment Privatfonds GmbHas of 02 Jan 2024 | 646.54k | 5.39% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 30 Apr 2024 | 133.58k | 1.11% |
| Mandatum Life Sijoituspalvelut Oyas of 30 Jun 2024 | 94.10k | 0.78% |
| Aktia Varainhoito Oyas of 30 Sep 2024 | 81.71k | 0.68% |
| Principal Verm�gensverwaltung AGas of 28 Jun 2024 | 65.00k | 0.54% |
| Fondita Fund Management Co. Ltd.as of 30 Sep 2024 | 61.00k | 0.51% |
| Cr�dit Mutuel Asset Management SAas of 29 Dec 2023 | 60.00k | 0.50% |
| Schroder Investment Management Ltd.as of 30 Jun 2024 | 57.60k | 0.48% |
| KBC Asset Management NVas of 30 Jun 2024 | 17.75k | 0.15% |
| UBS LA MAISON de Gestionas of 30 Dec 2022 | 16.73k | 0.14% |
More ▼
Data from 30 Jun 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
